Table 3.
Responders (n = 37) | Non‐responders (n = 6) | Responders versus non‐responders | |
---|---|---|---|
ESV (mL) | |||
Baseline | 144 ± 12 mL | 164 ± 40 mL | 0.67 |
Follow‐up | 84 ± 7 mL | 178 ± 47 mL | P < 0.01 |
Baseline versus follow‐up | P < 0.01 | 0.82 | |
EDV (mL) | |||
Baseline | 204 ± 14 mL | 247 ± 46 mL | 0.21 |
Follow‐up | 145 ± 9 mL | 246 ± 54 mL | P <0.01 |
Baseline versus follow‐up | P < 0.01 | 0.98 | |
EF biplane (%) | |||
Baseline | 31 ± 1% | 35 ± 3% | 0.19 |
Follow‐up | 44 ± 1% | 30 ± 3% | P<0.01 |
Baseline versus follow‐up | P < 0.01 | 0.22 |
EDV, end‐diastolic volume; EF biplane, ejection fraction measured from echocardiographic four‐chamber and two‐chamber views combined; ESV, end‐systolic volume.
Values are estimated marginal mean ± SEM.